CLGN Stock Analysis: Buy, Sell, or Hold?
CLGN - CollPlant Biotechnologies Ltd Ordinary Shares
$1.89
-0.02 (-0.84%)
▼
5d:
-0.53%
30d:
+35.0%
90d:
-14.09%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When CLGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLGN is currently trading at $1.89, which is considered extended relative to its 30-day fair value range of $1.40 to $1.78.
Technical Outlook: Technically, CLGN is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.99.
Market Sentiment: CLGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.56 (+511.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLGN is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.99.
Market Sentiment: CLGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.56 (+511.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.40 -
$1.78
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.2% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 511.6% below Wall St target ($11.56)
Fair Price Analysis
30-Day Fair Range
$1.40 -
$1.78
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$1.99
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-42.00
Wall Street Target
$11.56
(+511.6%)
Revenue Growth (YoY)
1825.0%
Last updated: February 01, 2026 11:06 PM ET
Data refreshes hourly during market hours. Next update: 12:06 AM
Data refreshes hourly during market hours. Next update: 12:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$213 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
